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The Need for a Test of Immunity against  Yellow Fever 
The study of the epidemiology of yellow fever would be  greatly 
facilitated by some simple immunity test which could be applied to 
human beings on a large scale.  With such a test it would be possible 
to determine whether yellow fever has been present in a region within 
the life of the present generation and to estimate the time and extent 
of the infection.  By testing an adequate number of persons in selected 
places, it should be possible to map large areas with regard  to  the 
endemicity, epidemicity, or  absence of yellow fever,  and  to  decide 
where control measures are necessary.  The test would be especially 
valuable where the disease is present but is seldom or never recognized, 
and also where there is confusion of yellow fever with other diseases, 
particularly leptospiral jaundice.  Such a test is needed also for deter- 
mining whether persons vaccinated against yellow fever by any of the 
proposed methods have  in  fact  been  immunized.  Just  at  present 
there  is  a  pressing demand for immunity tests  in  connection with 
yellow fever surveys of West Africa, whence aviation and other im- 
proved means of travel threaten to carry yellow fever past the little 
understood natural barriers to large susceptible populations in East 
Africa  and  the  Orient.  Numerous immunity tests  will  be  needed 
also for delimiting the endemic areas of Brazil. 
A very simple method of ascertaining whether a person is immune 
to yellow fever would be by a skin test, if a suitable antigen could be 
* The studies and observations on which  this paper is based were  conducted 
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found, but Frobisher (1) was unable to produce significant skin reac- 
tions  in  immune monkeys by  the  intradermal injection  of  any  of 
several antigens.  The methods of testing sera for their power to fix 
complement in the presence of yellow fever antigens, as developed by 
Frobisher (2) and Gordon Davis (3), seem to give specific results, but 
fixation does not take place as a rule in the tests of the sera of animals 
which have been immunized by vaccination without the production 
of fever, or in the sera of some of the highly immune persons who have 
recently had  yellow fever  (Hudson  (4)).  While  the method gives 
promise, it will not be ready for wide application, except as a supple- 
mentary test, until its limitations and methods of interpretation have 
been more exactly determined.  The protection test in Macacus rhe~sus 
monkeys, on the other hand, has proved reliable and highly useful, 
but it cannot be applied on a  scale large enough for present needs 
because too great a number of monkeys  would be required.  By testing 
human sera for their power to protect monkeys against yellow fever 
virus, Beeuwkes, Bauer, and Mahaffy (5) were able to determine the 
endemicity of yellow fever in parts of West Africa where cases were 
seldom recognized, and to show that certain other regions were free of 
the infection.  By this same test the identity of the recent isolated 
outbreak of yellow fever in the interior of  Colombia, described by 
Pefia Chavarria, Serpa, and Bevier (5), was confirmed in the laboratory 
in New York by Hudson and Kitchen (7). 
The protection test has many advantages and would meet the needs 
of the investigators in the field if a  larger number of sera could be 
examined than is possible when monkeys are used.  Any one of the 
potent African strains of yellow fever virus could be used in testing 
sera from any part of the world, for the serological identity of the 
African and American strains has been amply demonstrated by cross- 
immunity tests (Sawyer, Kitchen, Frobisher, and Lloyd (8))  and by 
the growing experience with protection tests in which sera from many 
parts of the Americas have protected against African strains of virus. 
The protection test can, as a rule, be depended upon to reveal immu- 
nity resulting from attacks of yellow fever no matter how long past. 
For example, specimens of serum from six persons who were ill during 
the epidemic in Norfolk, Virginia, in 1855 were obtained 75 years later, 
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virus (Sawyer (9)).  Protection tests of the sera of a  sutficient number 
of persons classified by location and age group would permit the recon- 
struction  of at  least  the  recent  yellow fever history of a  region  and 
would thus help in solving the present problem of control. 
The Susceptibility  of the Mouse to Yellow Fever 
When  the susceptibility of the  white mouse to  the  virus of yellow 
fever was announced  in  1930  by Theiler  (10,  11),  it seemed that  the 
laboratory animal needed  for replacing the monkey in the protection 
test had been found.  Working with the French strain of yellow fever 
virus from Africa, he discovered that adult mice could be infected by 
intracerebral inoculation but not ordinarily by subcutaneous or intra- 
peritoneal  injections. 
Theiler found that the virus was highly neurotmpic in mice and was abundant 
in the brain tissue after the disease had developed, although absent from the blood 
or liver.  There was a heightening of the virulence for mice with successive pas- 
sages in these animals, until a fixed strain for mice was produced which caused the 
death of all the animals inoculated intracerebraUy in approximately 5 days after 
injection.  Theiler showed that experimental yellow fever in mice took the form 
of an encephalitis with characteristic changes in the nuclei  of the ganglion  cells. 
Outside the nervous system the only lesion found which might be characteristic 
of yellow fever was hemorrhage into the stomach and intestines, but this occurred 
only in some of the infected animals.  He showed also that the sera of immune 
monkeys or persons had the power to prevent or defer the disease if mixed with the 
Virus before the intracerebral injection.  Variation of the length of time that the 
virus and serum were in contact before injection seemed to make no difference in 
the degree of protection.  Injections of large amounts of immune serum intraperi- 
toneally seldom protected against virus inoculated intracerebraUy. 
The Protection  Test by Intracerebral Inoculation  of Mice 
In a later publication Theiler (12) has presented experiments with a method for 
testing sera for their protective power against the fixed virus for mice.  He added 
each immune serum to an equal volume of a suspension of the virus, and inoculated 
mice intracerebrally with the mixture, using six or more mice in each test.  Control 
groups of mice received normal serum in the place of the immune serum.  Nearly 
all the control animals died from 5 to 9 days after inoculation.  Of the mice which 
had received immune serum, usually a  few died like the control animals, a  few 
more died from the 10th  to the 16th day, and several survived.  Even when  the 
virus suspension  contained only 1 per cent of virus and had been  centrifuged to 
remove all particles,  a  considerable  proportion  of  the  animals  which  received 
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permitted differentiation between immune and non-immurre sera, but the irregu- 
larity of the results would make it necessary to use an excessive number of animals 
to reach valid conclusions in testing large numbers of specimens.  If this test can 
be made more highly reliable by quantitative adjustments, it will have the advan- 
tage over the modified test which we shall describe of requiring only very small 
quantities of serum and virus. 
Establishment  of New Strains of Yellow Fever Virus in Mice 
In our study, the susceptibility of the white mouse to yellow fever 
virus when inoculated intracerebrally was confirmed. 
The Asibi strain of yellow fever virus of African source was established in mice 
by our associate in the laboratory, S. F. Kitchen, and we likewise established the 
S. R. strain from Brazil and the P. A. L. strain.  Theiler kindly let us have the 
French strain in its 95th passage in mice, and most of our work was done with this 
strain, which has now reached its 141st passage.  The Asibi strain has been carried 
through 51 passages, the S.R. through 21, and the P.A.L. through 15.  These new 
strains in  mice have  gradually become more  like the  fixed French strain,  but 
only the Asibi strain has reached a  point at which it may be considered as fixed. 
In Table I  are shown the intervals in days between the intracerebral inoculation 
of mice with each of these strains and the time when the animals were found dead 
or were killed when definitely ill.  The periods shown give a close approximation 
to the incubation periods, as the time interval between the observance of definite 
symptoms of weakness or partial paralysis and the death of the animal is usually 
short,  often only a  few hours  but not  infrequently  1 day.  Many of the mice 
inoculated with the French strain in the latest series in the table were killed so 
that  their brains could be used for inoculation.  If they had not been killed, a 
few of them would doubtless have died during the following night and their deaths 
would have been recorded as occurring 1 day later.  The differences shown in the 
table between the results with the earlier and the later passages of the French and 
Asibi strains of virus are of.doubtful significance.  The virus was already fixed in 
the earliest passages available for the comparison.  It is obvious, however, that 
both these fixed strains produce death in a  shorter time than do the two strains 
which have been passed through mice only a  small number of times.  The mor- 
tality is not shown in the table, as nearly all the mice died that were used in the 
experiments on which the table is based. 
Observations made before Nov., 1930,  are excluded from Table I, as many of 
our earlier experiments were made with a  strain of mice of low susceptibility to 
yellow fever virus, and the results were therefore not comparable with those in 
the table. 
With  Kitchen  we have  fully confirmed Theiler's observations (10) 
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produce  experimental  yellow  fever  with  typical  lesions  in  rhesus 
monkeys, but that the virus finally loses its power to produce fatal 
attacks in monkeys after many passages in mice.  We shall reserve 
details of these observations for a later paper by Kitchen and ourselves 
dealing  with  vaccination  against  yellow  fever.  The  pathology  of 
experimental yellow fever in mice is being studied by Kitchen and 
will be described by him in a later publication. 
Protection Test by Intraperitoneal Inoculation of Mice 
• In  applying the protection test  by  intracerebral  inoculation, we 
obtained results similar to those of Theiler, and came to the conclusion 
TABLE  I 
Effect of Numerous Passages of Yellow Fever Virus of Several Strains on the Time 
Interval  between Intracerebral Inoculation  and  Death 
Strain of 
yellow  fever 
virus 
French 
Adbi 
S.R. 
P.  A. L. 
No. of passages in mice 
Earlier:  105, 106, 107 
Latest:  138, 139, 140 
Earlier:  32,  33,  34 
Latest:  48,  50,  51 
Early:  3,  4, 
Latest:  19,  20,  21 
Early:  5,  6,  7 
Latest:  13,  14,  15 
No. of  animals dying, or  killed  when ill  t  after  each of the 
following intervals  in days after  inoculation 
8 
5 
2 
10 
5 
12 to 14 
that we could not expect the small amount of immune serum injected 
intracerebraUy to protect completely  and regularly against fixed yellow 
fever virus placed in direct contact with injured brain cells.  We there- 
fore sought some method by which more serum could be injected and 
the virus could be brought less directly and more slowly to the brain. 
It seemed probable that massive intraperitoneal injections of the 
virus in brain tissue would cause the introduced virus to circulate in 
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that yellow fever virus could be recovered for 2 or more days from the 
heart blood of several resistant animals inoculated in this way (guinea 
pig,  ferret,  bullfrog).  This  circulation  of  virus  was  evidently  not 
necessarily related to any infection either inapparent or obvious which 
might develop later,  because it occurred in  the entirely insusceptible 
bullfrog.  To enable the circulating virus to attack  the brain  of the 
adult  mouse it might be necessary to cause some mild injury of the 
brain  tissues,  because  simple  intraperitoneal  inoculation  alone  does 
not produce encephalitis in  the adult  animals.  If infection could be 
brought about in this way, it should be possible to test sera for protec- 
tive power by injecting them intraperitoneally in  adequate  amounts 
together with the virus and at the same time producing a  mild injury 
to the  brain. 
There were  precedents for the application of the principles  involved in  the 
method proposed.  Flexner and Amoss (14) reported in 1917 that"normal monkey 
or horse serum, isotonic salt solution,  and Ringer's and Locke's solutions,  when 
injected into  the  meninges,  promote infection with  the  virus  of poliomyelitis 
introduced into the blood, the nose, or the subcutaneous tissues."  Zwick, Seifried, 
and Witte (15) found out that the cutaneous inoculation of rabbits with Borna 
virus succeeds only in exceptional instances,  but that infection is easily brought 
about by such inoculation if at the same time an injury is produced in the central 
nervous system by the injection of non-specific fluids (normal rabbit serum, normal 
horse serum, or isotonic sodium chloride solution). 
The Agent for Localizing the Virus in the Brain 
In preliminary trims many fluids were injected intracerebrally into 
mice and compared for their effect in localizing yellow fever virus in 
the brain. 
The virus was injected intraperitoneally, as 0.2 cc. of a 10 per cent suspension 
of infected mouse brain, immediately after the anesthetized mouse had been given 
the intracerebral injection.  The substances  tested as the intracerebral inoculum 
were distilled water, 0.9 per cent and 3 per cent sodium chloride solutions, normal 
human and normal horse sera, solutions of magnesium chloride, magnesium sulfate, 
potassium alum, and manganese  chloride, 10 per cent extract of mouse testicle in 
0.9 per cent sodium chloride solution,  and solutions of corn-starch, tapioca,  and 
wheat flour.  Simple needling  of one or both sides of the brain was  tried also. 
Some of the salts were too toxic in the strengths of the solutions  used and were 
abandoned.  Others  of the  solutions  seemed to  have uncertain  or  inadequate 
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Satisfactory results were obtained with each of the three solutions 
of starch in either distilled water or 0.9 per cent sodium chloride solu- 
tion.  The 0.5  per cent magnesium  chloride  solution  seemed almost 
equally effective and was used in a considerable number of the earlier 
tests.  Our final choice of the fluid for injection in routine tests was a 
2 per cent solution of starch in 0.9 per cent sodium chloride solution 
injected intracerebrally in the amount of 0.03 cc., and this solution has 
been used in all the more recent tests. 
At the time of these early comparative tests we were using strains 
of mice of low and varying susceptibility and, as a result, an accurate 
comparison  was  impossible.  Working  more  recently  with  highly 
susceptible mice, we repeated many of these experiments  and  found 
that most of the mice succumbed to yellow fever encephalitis regardless 
of which substance was injected,  and even when the conditions were 
made less favorable by a  reduction in the amount of virus inoculated 
intraperitoneally.  Simply inserting  the  hypodermic needle into  the 
brain  often proved sufficient to establish the infection.  The  results 
of these recent tests are given in Table II.  While these tests would 
seem to allow considerable latitude in the choice of the intracerebral 
inoculum, we have decided to continue using the 2 per cent starch in 
isotonic sodium chloride solution.  It seemed to us probable that the 
slower  absorption  of  the  starch  and  the  presumably  more  definite 
injury to the tissues would make it more reliable than  simple needling 
or  the  injection  of  isotonic  salt  solution  alone.  In  any  event  the 
starch solution is proving effective in our experience with the protection 
tests in mice. 
The Intraperitoneal Inoculum 
In the production of experimental yellow fever in mice by the simul- 
taneous  injection  of  virus  into  the  peritoneal  cavity  and  a  mildly 
injurious substance into the brain, we found that a considerable propor- 
tion of the animals  escaped infection unless the amount of virus in- 
jected was large. 
In one comparative test the brain injury was prbduced by the injection of starch 
solution and the intraperitoneal  injection of virus consisted of a 10 per cent sus- 
pension of the brain  of an infected mouse in isotonic salt  solution.  An equal 
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TABLE  II 
Comparative Tests  of Mechanical Injury and the Injection  of Various  Fluids for 
Their  Power to Localize Yellow Fever Virus in the Brain of the Mouse 
Percentage o[  No. of mice  No. dying from  Per cent dying 
Fluid injected into brain to localize  infected mouse  inoculated and 
the vires (0.03 cc.)  brain in intra-  alive 4 days  5 to 10 days  within this 
peritoneal  inocu-  dter inoculation  period 
lure (0.2 cc.)*  later 
~o  fluid  (only  insertion  of 
needle) 
).9 per cent sodium chloride 
per cent sodium chloride 
).5  per  cent  magnesium 
chloridet 
.~ormal horse serum 
]0  per  cent  extract  of  mouse 
testielet 
2 per cent starch solutiont 
3ombined  results  with  all  of 
above injurious agents 
20 
5 
1 
20 
5 
1 
20 
5 
20 
5 
1 
20 
5 
1 
20 
5 
1 
20 
5 
1 
20 
5 
1 
12 
12 
11 
12 
12 
12 
6 
11 
11 
12 
11 
10 
12 
11 
9 
12 
ii 
10 
12 
12 
12 
78 
80 
75 
10 
7 
8 
10 
11 
6 
3 
8 
4 
10 
11 
6 
10 
6 
6 
10 
10 
5 
10 
9 
7 
63 
62 
42 
83 
58 
73 
83 
92 
50 
50 
73 
36 
83 
100 
60 
83 
55 
67 
83 
91 
50 
83 
75 
58 
81 
78 
56 
* Virus:  French strain  139th and  140th passages in mice.  Tests with the 20 
per  cent suspension were  made  together as one experiment, and  the other  tests 
comprised a  second experiment.  Each mouse received 0.4 cc.  of normal human 
serum in the first experiment and 0.4 cc. of a  10 per cent solution of normal human 
serum in 0.9 per cent sodium chloride solution in the second. 
t  Dissolved or suspended in 0.9 per cent sodium chloride solution. W.  A.  SAWYER AND  WRAY LLOYD  541 
of the brain suspension injected was 0.5 cc., all of ten mice inoculated died, but 
when the amount was 0.1 cc., only three of five mice died.  In another experiment 
the concentration of the virus suspension  was varied while the volume was kept 
constant at 0.2 cc.  Normal human serum (0.4 cc.)  was injected with the virus 
into each animal.  The intracerebral injection consisted of 0.03 cc. of 2 per cent 
starch. 
As is shown in Table III, the animals receiving virus in brain  sus- 
pensions  of  a  concentration  of  10  per  cent,  or over,  all  succumbed, 
while  a  considerable  proportion  of  those  receiving  suspensions  of  1 
per  cent  or  less  survived.  Likewise  in  the  experiments  reported  in 
TABLE  III 
Variation  of the Mortality Rate of Mice with the Amount of Virus in the I~traperi. 
toneal Inoculum 
Mouse brain in vires  No. of mice inoculated  No. of these mice dying 
suspension*  and alive 4 days later  5 to 10 days after  Mice dying 
inoculation 
per ce~i~ 
40 
20 
10 
1 
0.1 
0.01 
4 
5 
11 
5 
8 
8 
4 
5 
11 
3 
1 
1 
100 
100 
100 
60 
13 
13 
* Virus:  French strain, lllth passage in mice.  Volume of the virus suspension 
injected intraperitoneally, 0.2  cc.  With it was mixed 0.4  cc. of normal human 
serum.  Simultaneous  intracerebral  inoculum:  0.03  cc.  of  2  per  cent  starch 
solution. 
Table II the number of fatal infections  was much smaller when the 
intraperitoneal  inoculum was  a  1  per  cent  suspension  of virus  than 
when it was a  5 per cent suspension of the same virus. 
Evidently  the  chance  of producing  encephalitis  in  all  the  mice of 
a  group  inoculated  by  the  method  used  is  greater  when  the  larger 
quantities of virus are injected.  There are practical difficulties, how- 
ever, without compensatory advantages in using very large amounts. 
The observations in Table II show  that the use of even as much as 0.2 cc. of 
a 20 per cent suspension of brain virus may allow some of the animals to survive, 
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this amount of virus would often permit one mouse to survive, and sometimes two, 
in a group of six control animals receiving the virus with normal human serum. 
To secure the necessary amount of 20 per cent virus suspension for  the tests, 
approximately as many mouse brains were required as there were specimens to be 
tested, and this made necessary the inoculation of many animals as a  source of 
virus.  As the substitution of I0 per cent virus for 20 per cent made only a small 
difference  in the accuracy of the test, when highly susceptible animals were used, 
and resulted in a great saving of animals, we have recently adopted 0.2 cc. of 10 
per cent mouse brain virus as the virus component of the intraperitoneal  inoculum, 
and have paid special attention to the securing of suitable mice. 
Isotonic sodium chloride is the  fluid in which the brain was at first suspended 
in the preparation of the virus for inoculation, and  it is satisfactory if the virus 
is freshly prepared just before it is mixed with the  undiluted sera to be tested. 
In the light of the experience of Bauer and Mahaffy.(16), who found that the ad- 
dition o~ 10 per cent of normal monkey serum to diluted virus suspensions helped 
preserve the virus, we prefer to add this amount of a  normal serum  (human or 
monkey) to the salt solution used as a diluent in the test. 
We have found that 0.4 cc. of the serum is a satisfactory amount for the test. 
When this quantity is mixed with the virus suspension and injected, the test is 
so sensitive that sera from yellow fever convalescents diluted to 1 per cent usually 
protect a  considerable proportion of the mice. 
Technic of the Test 
Specimens to be Examined.--At  least 6 cc. of the serum to be tested is needed. 
The test requires 3 cc.  The remainder is used in case the results of the first test 
are doubtful or the control tests prove unsatisfactory. 
The Mice.--Healthy  young adult white mice of about 20 gin. weight are pre- 
ferred, but moderate differences in age do not seem to affect the results of the tests. 
A pure strain of mice, tested and found highly susceptible and bred on the premises, 
would give the best results.  Satisfactory work may be done with susceptible mice 
purchased from dealers, but each supply from a new source should be tested for 
susceptibility and there should be an understanding with the dealer that he will 
not change the source of his mice without notifying the laboratory.  During the 
test mice may be fed exclusively on bread soaked in milk, given once each day, 
and they will then require no water.  During the experiments the mice are kept 
in glass battery jars with wire mesh covers, six mice in each jar.  Wood shavings 
are placed in the jars, and the mice are moved to fresh jars 1 week after inoculation. 
Preparation of the Virus.--An  approximate time is set in advance for the tests, 
preferably 2 or 3 consecutive days in the middle of the week.  5 days before each 
testing date, a  sufficient number of healthy mice are inoculated intracerebrally 
with yellow fever virus in mouse brain tissue.  The mice are inspected each morn- 
ing.  The definitely sick animals are killed with chloroform and are pinned out, 
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lesions of any disease other than yellow fever and  to drain the blood from the 
brain.  The only gross lesion probably due to yellow fever, which has been oh- 
served, is hemorrhage into the stomach and intestines, and this is absent in most 
cases.  The mouse is  then  turned over and pinned out.  The skin is slit with 
scissors from the nose to the middle of the back and the flaps are laid back.  An 
assistant sears the top of the skull with a  red-hot soldering iron.  The operator 
removes the bony covering over the brain with sterile sharp-pointed scissors and 
then spoonsout the brain with a rigid, narrow spatula of nickel.  The brain is placed 
in a  small, weighed petri dish.  The other brains secured are placed in the same 
dish and the total weight is ascertained.  The brains are then finely ground up in 
a  porcelain mortar with enough isotonic salt solution, or preferably salt solution 
• containing I0 per cent of normal serum, to make a I0 per cent suspension. 
Preparation  of the Serum-Virus Mixtures.--In  advance of the  tests, 3  cc.  of 
each specimen of serum or diluted serum and of each of several sera for the controls 
is placed in a small test-tube.  If less than 3 cc. of serum is available for a test, a 
50 per cent solution of the serum may be tested if the dilution is stated in the 
report.  If less than 1.5 cc. is received, we discard the specimen unless its unusual 
importance justifies testing it in higher dilutions.  To each tube is added 1.5 cc. 
of the virus suspension.  The contents of each tube are mixed and drawn up into 
a  5  cc. graduated glass syringe with the number of the specimen or that of the 
mouse group to be inoculated written on it with a wax pencil. 
The Starch Solution.--The starch solution for intracerebral injection is prepared 
in advance by adding 2 per cent of corn-starch, such as is sold for food, to the 0.9 
per cent sodium chloride solution and heating in a flask in a bath of boiling water. 
The solution is then placed in small wide mouthed Erleumeyer flasks, autoclaved, 
and stored ready for use.  In the morning of the day of the tests the starch solution 
is drawn up into tuberculin syringes of 0.25 cc. capacity, fitted with hypodermic 
needles 0.42 ram. in diameter (Stubsgauge No. 27) and 10 mm. long.  The number 
of syringes filled is the same as the number of mouse groups to be inoculated. 
Controls.--With  each set of tests there should be five control groups of six mice 
each.  Two groups should receive 0.4 cc. of normal serum  (human  or monkey) 
in place of the unknown serum of the test, and two should receive a known immune 
serum (human or monkey).  To conserve the immune serum, it may be diluted to 
10  per  cent  if of sufficiently high titer.  The fifth control  should  be given  the 
virus mixture intracerebrally.  It shows whether the mice are susceptible and the 
virus potent.  Intracerebral inoculation brings  the animals down  1  day sooner 
than intraperitoneal inoculation with simultaneous cerebral injdry. 
An important object of the immune serum control is to show that the deaths 
caused by the virus suspension injected are in reality due to yellow fever and not 
to some contaminating organisms in the virus mixture.  In our recent experience 
the most frequent cause of an unsatisfactory result requiring repetition of the tests 
is contamination of the virus as revealed by deaths of mice in the immune  serum 
control groups.  The organism of mouse typhoid, Strain 1, was isolated from the 
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attempting to diminish this difficulty  by using healthy mice of our pure strain bred 
on the premises for source of virus and inoculating them from mixtures containing 
the smallest possible number of brains.  When it seems advisable as an additional 
precaution, we filter the brain suspension used in inoculating the source animals 
through Berkefeld N  filters.  It would be possible also to go back to stored, dried 
specimens of the virus which were obtained when it was apparently free from con- 
tamination.  Before  filtering the  virus,  the  brain  suspension  should  be  centri- 
fuged and the sediment discarded.  The mouse brain virus may be easily preserved 
by preparing a suspension of the brain tissue in normal human or monkey serum, 
placing it in 1 cc. amounts in test-tubes, drying it in the frozen state, and then seal- 
ing the tubes and storing in the refrigerator.  We have already preserved the virus 
in this way for several months.  The essentials of the method have been published 
by Sawyer, Lloyd, and Kitchen (17). 
Inoculation  of the Mice.--An assistant anesthetizes the mice by placing several 
in a battery jar, on the bottom of which is a layer of cotton moistened with ether. 
The mice are taken from the jar when they become unconscious and are laid on 
the table near the operator.  The operator, wearing rubber gloves, takes a mouse, 
lays it back up on a towel on the table, parts the hair of the head with a swab wet 
with  70 per cent alcohol and  thrusts  the  fine needle of  the  tuberculin syringe 
through the thin skull and into the center of the brain.  He injects  0.03  cc. of 
the starch solution.  The mouse is then picked up by the skin of the neck, and its 
tail is held by the third finger of the same hand.  With one of the larger syringes 
an intraperitoneal injection of 0.6 cc. of the virus-serum mixture is given.  ~rhe 
mouse is then dropped into a numbered jar.  One operator with an assistant can 
test up to 25 sera on each of 3 days of the week ff he has an  abundance of equip- 
ment ready in advance.  The actual  injections require approximately 3  minutes 
for each mouse group. 
Inspection  and Recording.--The mice are inspected every morning for 14 days, 
and a record is made of those that are sick or dead.  Our printed record form on 
cards measuring 77 by 128 ram. is shown in Fig. 1.  The first mouse  to  become 
sick or die becomes Mouse 1 of the group, and the second, No.  2, and so forth. 
Interpreta21on of the Results.--The result of the protection  test is  recorded as 
the ratio of the number of mice surviving on the 10th day after inoculation to those 
that were alive and well on the 4th day, and this is followed in parenthesis by the 
corresponding ratio for the control groups receiving normal serum with virus, thus: 
"5/6 (0/12)," meaning that 5 out of 6 mice survived in the test group and none of 
12  in  the  normal serum  control groups.  Deaths  before the  5th day are in all 
probability not due to the yellow fever virus.  Unless a note is made to the effect 
that  the  control groups receiving immune serum and virus gave unsatisfactory 
results, it is to be assumed that the mice in these groups were protected.  From 
the record cards the results are then classified as "protection," "no protection," 
"inconclusive," or "unsatisfactory," in accordance with the requirements of the 
guide given in Table IV.  Unless a  very few deaths in the "protection" groups 
and a similar number of survivals in the "no protection" groups were allowed, the W.  A.  SAWYER  AND  WRAY  LLOYD  545 
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FIG. 1.  Part of record of test of a serum by the intraperitoneal protection test 
in mice, to determine protective power against yellow fever.  Upper card contains 
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"inconclusive" and "unsatisfactory" results would be excessively numerous  and 
many tests would have to be repeated.  Our experience leads us to consider the 
requirements in the table to be conservative.  Very rarely there may be a number 
of deaths on the llth or 12th days after inoculation, in which case it may sometimes 
he  justified to classify the  result as "inconclusiVe"  when it would otherwise be 
"protection."  Ordinarily the  deferring of death beyond the  10th  day shows a 
considerable protective action of the serum and would have almost the same sig- 
nificance as a survival.  If the amount of serum will permit, the tests of the speci- 
mens  in  the  "incondnsive"  and  "unsatisfactory"  groups  are  repeated,  and  if 
definitely positive or negative results are then  obtained they are accepted, but 
TABLE  IV 
Guide for Interpretation of Results of the "Intraperitoneal Protection Test" in Mice 
No. of mice living and well 4 days 
after inoculation 
1, 2, 3 
4 
5, 6 
7, 8, 9 
10, ll, 12 
No. of deaths or  survivals  allowed among these mice 5 to I0  days after 
inoculation  if  the report is  to be "protection" or  "no protection," 
respectively* 
Protection (-4-) 
No. of deaths allowed 
No protection or negative (-) 
No. of survivals  allowed 
Result "unsatisfactory" (U) in any case 
0  I  ° 
1  1 
2  2 
3  3 
* If  there  is neither  "protection"  nor  "no  protection"  but  the  controls are 
satisfactory, the result is classed as "inconclusive" (±).  If the results with  the 
normal serum and known immune serum controls are not "no protection"  and 
"protection," respectively, in conformity with the standards of the table, all the 
tests to which the controls relate are classed as "unsatisfactory" (U).  If possible, 
all "inconclusive" and "unsatisfactory" tests are repeated. 
the protection ratios for both tests are shown in the tabular reports to the senders 
of the sera.  The "unsatisfactory" results include those in which the controls are 
unsatisfactory and those in which fewer than four mice are alive and well 4 days 
after inoculation. 
Bacteriological and  Pathological Examinations.--Ordinarily  the  identification 
of the probable cause of death of the mice in the routine tests rests on the known 
source of virus and the fact that in the controls the known immune yellow fever 
serum protects the mice and the normal serum does not.  If there are circum- 
stances suggesting that  deaths may be  due  to  contamination of the  individual 
specimen of serum, cultures may be taken of the serum and histological examina- 
tions may be made of the brains of the mice.  Such difficulties are rarely encount- W.  A.  SAWYER  AND  WRAY  LLOYD  547 
ered if the sera are collected wit  h great care and in sufficient quantity.  The test 
is hardly worth while if a  shipment of sera contains many specimens that  are 
contaminated or below 3 cc. in amount. 
Demonstration  of  the  Presence  of  Virus  in  the  Blood  of the  Mouse 
The  intraperitoneal  protection  test  in  mice  was  devised  on  the 
supposition that yellow fever virus injected into the peritoneal cavity 
quickly found its way into the blood stream and was carried through 
the  blood  vessels of  the  brain.  Theiler  had  shown  that  the  blood 
contained little or no  virus during the  course  of the  disease,  and we 
were unable to find virus in the blood after symptoms  had appeared. 
To demonstrate  the virus in the circulating blood after inoculation 
and its absence during the course of the yellow fever encephalitis, we 
carried out the experiments recorded in Table V. 
In the principal experiment, mice were each given intraperitoneal injections of 
0.2 cc. of a 20 per cent suspension of brain virus, French strain, 124th passage in 
mice, together with 0.4 cc. of normal human serum.  The amounts of virus and 
serum were  the  same as were  then  being used in our routine protection tests. 
The mice were divided into two series, A and B.  One group of mice of Series A 
was bled from the heart under ether anesthesia 24 hours after the injection.  Other 
groups were similarly bled 48, 72, 96, and 120 hours after inoculation.  The blood 
of each group was  heparinized and  mixed and  then  injected intracerebrally in 
amounts of 0.03 cc. into groups, of normal mice as a test for the presence of virus 
in the injected blood.  The r~esults are shown in Table V.  A  considerable but 
irregular proportion of the mice inoculated died within the usual time period for 
deaths from experimental yellow fever after intracerebral inoculation of fixed virus 
(4 to 9 days after inoculation). 
The mice of Series B were bled in the same way, but the fresh untreated blood 
of each individual mouse was injected immediately into a  group of normal mice. 
As before, the injections were intracerebral and consisted of 0.03 cc. of blood.  The 
times of bleeding were the same except that the bleedings after 120  hours were 
omitted.  The results were similar to those of Series A. 
In the first supplementary test recorded in Table V, mice were inoculated as in 
the principal test.  The virus was of the French strain, 108th passage in mice, 
and 0.2  cc. of a  20 per cent suspension was injected intraperitoneally into each 
mouse.  The mice were bled 24 hours later and the blood was pooled and allowed 
to clot.  The serum was injected into normal mice intracerebrally in amounts of 
0.03  cc.  The result was almost identical with that obtained in Series A  of the 
principal experiment with the inoculation of pooled whole blood after the same 
time interval.  Of eleven mice inoculated with the serum and surviving on the 
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In the second supplementary test,  the mice were inoculated intraperitoneaUy 
with the same amount of virus, French strain,  109th and ll0th passages in mice, 
mixed  with  normal  human  serum,  but  they  were  given  also  an  intracerebral 
TABLE  V 
Recovery of Ydlow Fever Virus from the Circulating Blood of Mice at Varying Inter- 
vals after Massive Intraperitoneal Inoculation 
Principal Experiment, Series A 
No.  of  mice  bled  as  source  (blood 
heparinized and pooled) 
No.  of  mice  inoculated  intracere- 
brally with the  mixed  blood and 
alive 3 days later 
No. of these mice dying or moribund 
4 to 9 days after inoculation 
Principal Experiment, Series B 
No. of mice bled as source (untreated 
blood of each use  d separately) 
No. of mice inoculated in groups with 
these  separate  bloods and alive 3 
days later 
No. of these mice dying or moribund 
4 to 9 days after inoculation 
Supplementary Experiments 
No.  of  mice  bled  as  source  (blood 
pooled) 
No.  of  mice  inoculated  with  the 
mixed  serum  and  alive  3  days 
later 
No. of these mice dying or moribund 
4 to 9 days after inoculation 
Hours between inoculation  and bleeding of  source  animal 
24 
(1 day} 
5 
11 
5 
25 
6* 
11 
48 
(2 days) 
5 
10 
5 
22 
4 
10 
! 
5 
24 
13 
96 
(4 days) 
4 
10 
4 
19 
2o 
(S lays) 
2 
10 
144 
(6 days) 
4t 
16 
* First supplementary  experiment. 
t Second supplementary experiment. 
injection of 0.03  cc. of 3 per cent starch solution to localize the virus and permit 
infection to take place.  In this way it was hoped to find out whether the virus 
would disappear by the 6th day after injection, and, if it did, to ascertain whether 
it would reappear with the appearance of symptoms.  Four of the mice which were W.  A.  SAWYER  AND  WRAY  LLOYD  549 
moribund or definitely ill 6 days after inoculation were anesthetized and bled from 
the heart.  The mixed serum was injected intracerebrally, in the amount used in 
the previous experiments, into sixteen normalmice.  Allof these mice remained weU 
throughout the observation period of 14 days.  The four mice whose blood had 
been taken for injection were killed and their brains were ground up together to 
make a  20 per cent suspension.  Twelve mice were inoculated intraperitoneally 
each with 0.2 ce. of this suspension mixed with 0.4 cc.  of normal human serum. 
Twelve other mice were similarly inoculated, but a known human immune serum 
was substituted  for the normal serum.  All the mice were given also 0.03  cc. of 
3 per cent starch solution intracerebrally.  Of the mice receiving normal serum, 
one died early, and the remaining eleven died from 5 to 8 days after inoculation. 
Of the twelve receiving immune serum, all but one remained well for the entire 
observation period of 14 days.  Thus was shown the presence of the virus in the 
brain and its identity as yellow fever virus.  Evidently the virus had disappeared 
from the blood before the 6th day after inoculation and had not reappeared with 
the onset of the encephalitis and the production of much yeUow fever virus in the 
brain  tissues. 
While the evidence from these several experiments strongly suggests 
that  yellow fever  virus  was present  in  the  circulating  blood  of mice 
every  day  from  the  1st  to  the  5th  after  intraperitoneal  inoculation 
and caused all,  or most of, the deaths in the mice inoculated with the 
blood specimens, the presence of the virus has been confirmed by histo- 
logical examinations  and  subinoculations  only for specimens of  blood 
taken  24  hours,  48  hours,  and  96  hours  after  inoculation.  The  evi- 
dence  follows. 
Serum Taken after 24 Hours.--(First supplementary experiment, Table V.)  One 
of the mice which had been inoculated with the serum was killed when moribund, 
and part of its brain was examined histologically.  There were definite lesions of 
encephalitis, typical of those seen in yellow fever in the mouse.  Half of the same 
brain was ground up with half the brain of another mouse in the same group, and 
normal mice were inoculated intracerebrally with the suspension.  Of twelve mice 
alive on the 3rd day after inoculation, eleven died from 4 to 9 days after inocula- 
tion, and the brain of one was examined and found to show pronounced and typical 
lesions of yellow fever encephalitis.  Further subinoculations were made similarly 
from this group, and of seventeen mice alive on the 3rd day, fifteen died from 4 to 
9 days after inoculation.  The brains of two other mice of the group receiving the 
24 hour serum were ground up  together and used in inoculating eighteen mice 
intracerebrally.  All of them died 4  to 6  days later.  The brains of two were 
examined and found to show lesions of encephalitis. 
Blood Taken after48 Hours.--(Principal  experiment, Series B, Table V.)  Brain 
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brally into normal mice.  Of ten alive on the 3rd day, all died or were moribund 
5 to 6 days after inoculation.  The brains of two were examined  histologically  and 
found to present lesions of encephalitis consistent with those of yellow fever. 
Blood Taken after 96 Hours.--(Principal  experiment, Series B, Table V.)  One 
of the mice which had been inoculated with 96 hour blood was killed when mori- 
bund, and part of its brain was examined  histologically.  The lesions of encephali- 
tis were present and considered to be those of yellow fever.  The remainder of 
this brain was ground up with the brain of another mouse in the same group, and 
twelve mice were inoculated intracerebrally with the  suspension.  All died or 
were moribund 5 days later.  The brain of one was examined  and found to present 
the picture of yellow  fever encephalitis. 
From these observations it seems that the mouse is unique, among 
the animals so far investigated, with regard to the circulation of yellow 
fever virus in its blood, inasmuch as the virus in the blood disappears 
before symptoms begin and does not reappear with the onset of obvious 
disease.  After massive intraperitoneal inoculation the virus appears 
promptly in the blood and remains for several days.  If the  virus in 
the  circulating blood  is  given  an  opportunity to  attack  the  brain 
through  a  local injury and  produces  disease  on  the  6th  day  after 
inoculation, the virus is absent from the blood at the time the symp- 
toms begin,  although it is abundant in the brain  tissue.  It  would 
seem that the mouse, like many other animals, permits the  injected 
virus to circulate for a time regardless of whether a manifest infection 
is to take place, and that the virus disappears from the blood after a 
few days.  If the encephalitis of yellow fever occurs later, the virus 
does not reappear in the blood.  We do not yet know whether protec- 
tive substances against yellow  fever are produced in the mouse by 
!ntraperitoneal inoculation in the absence of the production of yellow 
fever  encephalitis,  but  protective  substances  have  been  shown  to 
appear  in  several other resistant warm blooded  animals after such 
inoculation (13).  There is a possibility that the rise of antibodies in 
the blood frees the blood of virus while permitting virus to continue 
its development or to persist in the central nervous system, just  as 
yellow fever virus might remain for a  time in the liver of an infected 
monkey after it had disappeared from the  circulation with the rise 
of antibodies.  We do not know whether the virus in the circulating 
blood increases in amount or is simply the virus introduced by massive 
inoculation.  ~Vhatever the process is that permits virus to be recov- W.  A.  SAWYER  AND  WRAY  LLOYD  551 
ered from the blood, it seems evident that it does not depend on the 
production of the encephalitis which characterizes experimental yellow 
fever in the mouse. 
Differences in the Susceptibility  of Strains of Mice to Yellow Fever Virus 
In the first months of our study, while using the strain of white 
mouse bred at The Rockefeller Institute for general purposes, we were 
disappointed in the seeming low virulence of the virus strains used. 
Even the fixed French strain, which had become so highly virulent in 
the hands of Theiler (11), allowed many of the mice to survive after 
intracerebral inoculation.  We found the mortality too low at  that 
time to permit the development of a  satisfactory protection test in 
mice.  In October, 1930, there was an abrupt rise in the mortality to 
approximately 100 per cent, and we observed that this coincided with 
the purchase of mice from Dealer K  at a time of shortage of the Insti- 
tute stock.  We later secured strains from other sources and tested 
their susceptibility.  Through the kindness of Dr. Carrel we received 
mice of the Dilute Brown strain and of the albino Swiss strain.  The 
latter strain had been brought to the Institute by Dr. Clara Lynch in 
1926 from the laboratory of Dr. de Coulon of Lausanne, Switzerland. 
Mice were secured also from three dealers, K, M, and D. 
The  results  of  comparative  tests  for  susceptibility  are  shown  in 
Table VI, and may be briefly summarized.  Of the three pure strains, 
the Swiss and the Dilute Brown were found to be highly susceptible 
and suitable for use in the protection test.  The mortality was nearly 
100 per cent for both strains, but the incubation period was slightly 
shorter in the Dilute Brown mice than in the Swiss. 
The Institute stock strain  was remarkably resistant.  This resis- 
tance was manifest even in suckling mice.  Unlike adult mice, very 
young mice will  ordinarily contract yellow fever encephalitis when 
inoculated  by  intraperitoneal  injection  in  the  absence  of  cerebral 
injury,  as  has  been  shown  by  Theiler  (11).  Suckling mice of the 
Institute stock, however, were found to be highly resistant to intra- 
peritoneal inoculation, while similar mice from Dealer K  were very 
susceptible. 
This experience brings out the importance of using a pure strain of 
mouse of known susceptibility in yellow fever studies and protection 552  USE  OF  MICE  IN  YELLOW  FEVER  IMMUNITY  TESTS 
TABLE  VI 
Comparative  Tests of Strains of Mice for Susceptibility to Yellow Fe~er Virus of the 
French Strain  after 109 to  138 Passages in Mice 
Pure strains  Mixed strains 
Comparative tests 
Swiss  Dilute  Insti-tute Dealer  Dealer  Dealer 
Brown  stock  K  M  D 
Intracerebral Inoculation  of  Young 
Adult  Mice* 
Test  No. of mice.. 
Percentage  dead  or  moribund 4 
to 9 days after inoculation  ..... 
Test  No. of mice.. 
Percentage dead or moribund .... 
Test  No. of mice.. 
Percentage dead or moribund .... 
Test 
Test 
No. of mice.  30  30 
Percentage dead or moribund ....  100%  100% 
No. of mice.  23  24 
Percentage dead or moribund ....  100%  100% 
No. dead or moribund on 4th day 
after inoculation.  3  17 
No. dead or moribund on 5th day 
after inoculation.  19  7 
55 
65% 
48 
5O% 
52 
96% 
95 
98% 
53 
t00% 
3O 
83% 
23  22 
loo%  i0o% 
7  2 
16  20 
54 
81% 
Intraperitoneal Inoculation of Suck- 
ling Mice 13 to 16 Days Oldt 
Test 6  No. of mice. 
Percentage dead or moribund 5 to 
10 days after inoculation.. 
No.  dying  11  to  15  days  after 
inoculation. 
13  18 
0%  83% 
4  t 
* Inoculum:  10 per  cent  suspension  of  brain of  moribund mouse  in  isotonic 
sodium  chloride solution.  Amount injected intracerebraUy:  0.03  cc. 
t  Same inoculum as used  intracerebrally.  Amount injected intraperitoneaUy 
into suckling mice:  0.1 cc. W.  A.  SAWYER  AND  WRA¥  LLOYD  553 
tests.  Unfortunately,  this  is  not  always  possible,  and  we  are  still 
compelled to buy reasonably susceptible mice of unknown  and mixed 
heredity  from dealers,  while  an insufficient  but  increasing  supply of 
mice of the Swiss strain is being bred for us. 
Titration of Sera for Protective Power 
The  technic  of  the  intraperitoneal  protection  test  in  mice  is  well 
adapted  to  the  titration  of  sera  for  their  protective  power  against 
yellow fever.  It is merely necessary to  substitute  serial dilutions  of 
the  serum  for the  full  strength  serum  in  the  test.  The  methods  of 
recording and interpreting  remain the same. 
We may take as an example the results of a titration in a study of the persistence 
of yellow fever immunity (9).  The serum was from a woman who had had yellow 
fever 78 years before.  The upper card in  Fig.  1 shows  the  record of the  full 
strength  serum  in  this  titration.  The  controls  were  satisfactory;  the  normal 
serum controls permitted only one of eleven mice to  survive.  The protection 
ratios and results for the several dilutions were: dilution  1:1, 6/6  (+)  meaning 
that six mice out of six survived; 1 :  2, 6/6 (+); 1 :  4, 6/6 (+);  1 : 8, 4/5 (+);  1 : 16, 
4/6 (4-); 1:32, 4/6 (4-); 1:64,  1/6 (-);  1:128,  1/6 (-).  By the rigid standard 
of Table IV, the specimen of serum protected in dilutions up to  1:8, and  gave 
inconclusive  results at 1:16 and 1:32, and gave no protection in higher dilutions. 
The titer would be 1:8. 
Sensitivity  of the Test 
The intraperitoneal  protection  test in mice is much more sensitive 
than  the  protection  test  as  made  in  monkeys.  Sera  which  protect 
monkeys  also  protect  mice,  but  many  which  protect  mice  do  not 
protect monkeys. 
The serum which was mentioned above as protecting mice in a dilution of 1:8 
was tested also in two monkeys.  One was given 3 cc. of the serum per kilo of body 
weight and the other 1.5 cc. per kilo by intraperitoneal injection, and each received 
a subcutaneous injection of 0.4 cc. of Asibi yellow fever virus in monkey blood 6 
hours later.  All of three control animals died of yellow fever.  The test animals 
both  developed fever and  recovered,  showing  that  they  had  received definite 
protection but of a low degree.  The sera of several persons who have recovered 
in recent years from laboratory infections usually protect  monkeys  completely 
when as much as 1 cc. per kilo is injected and protect mice when the dilution of the 
serum is 1 : 50 or 1 : 100.  The intraperitoneal test in mice has been found sufficiently 
sensitive to reveal active immunity in persons and monkeys successfully protected 554  USE  OF  MICE  IN  YELLOW  FEVER  IMMUNITY  TESTS 
against yellow  fever by means of inoculation with mixtures of immune serum and 
mouse  brain virus. 
Danger to Personnel 
Unusual  precautions  are  necessary  to  prevent  the  infection  of 
laboratory  personnel  with  yellow  fever  virus  from  infected  mice. 
Three such infections are known to  have occurred.  We have  con- 
sidered it necessary to limit  the personnel working in  the rooms in 
which the mice are inoculated  and  the  brains  removed, to  persons 
known to have become immune to  yellow fever as  the  result  of an 
attack of the disease or through vaccination. 
SUMMARY  AND  CONCLUSIONS 
1.  A method of testing sera for protective power against yellow fever 
is  described  and  designated  as  the  intraperitoneal  protection  test 
in mice. 
2.  The  test  consists  essentially of the  inoculation of mice intra- 
peritoneally with yellow fever virus, fixed for mice, together with the 
serum to be tested, and the simultaneous injection of starch solution 
into  the brain  to  localize  the virus.  If the  serum lacks protective 
power the mice die of yellow fever encephalitis. 
3.  The test is  highly sensitive.  Consequently it is  useful in epi- 
demiological studies to determine whether individuals have ever had 
yellow fever and in tests to find whether vaccinated persons or animals 
have in reality been immunized. 
4.  When mice were given large intraperitoneal injections of yellow 
fever virus fixed for mice, the virus could be recovered from the blood 
for 4 days although encephalitis did not occur.  If the brain was mildly 
injured at the time of the intraperitoneal injection, the symptoms of 
yellow fever encephalitis appeared 6 days later, but the virus was then 
absent from the blood. 
5.  Strains  of  white  mice  vary  greatly  in  their  susceptibility  to 
yellow fever. 
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